• Cellesce is now part of Molecular Devices

    Cellesce is now part of Molecular Devices, a life sciences innovator enabling screening of 3D cell models and human systems at scale to advance drug discovery.

    Learn more

  • Scale-up of Patient-Derived Organoids (PDOs)

    Cellesce uses its proprietary bioprocess and bioreactors for the expansion of human-derived normal and cancer PDOs for multiple applications, including drug screening.

    Learn moreContact us

  • Research and Development

    Cellesce’s Research & Development continues to generate key data on the application of PDOs in biotech and pharma.

    Learn moreContact
    organoid research

  • PDO Pipeline

    We have colorectal and breast cancer PDOs established at Cellesce as well as normal colon and duodenal organoids. Our future pipeline includes, pancreatic, lung and liver PDOs amongst others.

    Learn moreContact
1234

WHAT WE DO

Banked organoids

Commercially Available PDOs

PDOs grown at scale using our proprietary bioprocess, commercially available off-the-shelf.

LEARN MORE
Bespoke development

Fee-for-Service Development and Manufacturing

Bespoke ‘Fee-for-Service’ development and scaled manufacturing of any (compatible) PDO lines.

LEARN MORE
Patient Derived Organoid

Enablement of PDO Technology

Full pipeline support for the enablement of PDO technology, from sourcing, line development, technology access, QMS and know-how.

LEARN MORE

NEWS

organoid culture
Cellesce Patent Granted
LEARN MORE
Vicky Marsh-Durban
Vicky Marsh Durban Appointed CEO
LEARN MORE

WHY CELLESCE?

Cellesce’s research and development continues at pace encompassing these main business drivers:
Scale-up and bioprocessing
Expand organoid tissue types and lines
Morphometry
Immuno-oncology
Cellesce continues to build relationships within the organoid ecosystem to enable this patient centric technology and to drive forward PDO utilisation earlier in R&D.

OUR PARTNERS